Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
Dr. Boesen is the founder and CEO of SinfoniaRx, which was acquired by TRHC in 2017. He brings more than 15 years of experience in healthcare sales, including healthcare information technology solutions and services. He has demonstrated his sales generation, marketing, strategy and leadership capabilities in connection with his work building SinfoniaRx into one of the largest medication therapy management platform companies in the U.S. SinfoniaRx provides medication management services for more than 450 health plans representing more than 10 million patients, including 8 million
“Dr. Boesen’s enthusiasm and vision for the future of an integrated technology and service offering to health plans is exciting and exactly where we can further enhance outcomes through the application of the MedWise platform, including the Medication Risk Score™, and where we can leverage our consumer engagement toolkit, MyMedWise™,” said
Dr. Boesen noted, “Since joining TRHC in the fall of 2017, I have seen great opportunities to help our current and new health plan clients enhance quality and reduce total costs through the use of TRHC’s technology platform offering. The problem we are addressing is adverse drug events, the fourth leading cause of death in
Creating a dedicated sales organization will support the sales and cross-selling efforts next year and into the future. Starting
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Forward-looking statements give current expectation or forecasts of future events or our future operating performance, and include TRHC’s expectations regarding healthcare regulations, industry trends, available opportunities to TRHC and operating performance of TRHC, including with respect to acceptance and adoption of TRHC’s product offerings. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management's good-faith expectations, judgements and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the acceptance and use of our products and services by health plans, healthcare systems, PACE organizations and other at-risk healthcare organizations; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the
|Dianne Semingson||Bob East or Asher Dewhurst|
|T: (443) 213-0500|
Source: Tabula Rasa HealthCare, Inc.